Literature DB >> 22536934

TNF-α expression in the UCB-MSCs as stable source inhibits gastric cancers growth in nude mice.

Weizheng Mao1, Xinhong Zhu, Dongqi Tang, Yuanyuan Zhao, Baocheng Zhao, Guiliang Ma, Xuebin Zhang, Gang An, Yang Li.   

Abstract

Mesenchymal stem cells (MSCs) are potentially vehicles for therapy of malignant diseases. In our study, we investigated whether UCB-MSCs are capable to carry TNF-α to target tumor cells in vivo. The human gastric cancer cells SGC-7901 were subcutaneously injected into the abdomen near groins of 15 nude mice to establish experiment tumor models. MSC-TNF-α demonstrated a strong suppressive effect on the tumor growth compared with MSC and NaCl. Thus, MSC-TNF-α can obviously inhibit Gastric cancers growth in nude mice, indicating that UCB-MSCs may have the potential to become a prevention approach against gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22536934     DOI: 10.3109/07357907.2012.675385

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  4 in total

1.  Purification of a Pd20-TNFα fusion protein that prevents liver metastasis of gastric cancer.

Authors:  Sheng-Juan Hu; Rong-Xing Jiang; Hua-Hong Xie; Ai-Ling Ma; Hong-Li Shi; Hao Shen; Zhi-Ming Hao
Journal:  Tumour Biol       Date:  2014-05-02

Review 2.  Mesenchymal stem cells as professional actors in gastrointestinal cancer therapy: From Naïve to genetically modified.

Authors:  Mehrdad Nasrollahzadeh Sabet; Masood Movahedi Asl; Mahtab Kazemi Esfeh; Navid Nasrabadi; Maryam Shakarami; Behrang Alani; Asma Alimolaie; Sara Azhdari; Ebrahim Cheraghi
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

3.  The tRNA-derived fragment 5026a inhibits the proliferation of gastric cancer cells by regulating the PTEN/PI3K/AKT signaling pathway.

Authors:  Linwen Zhu; Zhe Li; Xiuchong Yu; Yao Ruan; Yijing Shen; Yongfu Shao; Xinjun Zhang; Guoliang Ye; Junming Guo
Journal:  Stem Cell Res Ther       Date:  2021-07-22       Impact factor: 6.832

Review 4.  Immunotherapeutic organoids: a new approach to cancer treatment.

Authors:  Marta Compte; Natalia Nuñez-Prado; Laura Sanz; Luís Alvarez-Vallina
Journal:  Biomatter       Date:  2013-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.